{
    "address": "Vasagatan 16",
    "city": "Stockholm",
    "country": "SE",
    "currency": "SEK",
    "cusip": "W5169F115",
    "description": "Irras AB engages in the development, design, and commercialization of solutions for the treatment of brain pathologies. The company is headquartered in Stockholm, Stockholm and currently employs 51 full-time employees. The company went IPO on 2017-11-22. The company offers devices for fluid control and management for a broad range of brain pathologies, central nervous system (CNS) therapeutic applications and procedures. The offer comprises instruments and catheters for the clinical, monitoring and surgical applications for brain pathology indications called IRRAflow. The IRRAflow CNS System combines an External Drainage System, an intracranial pressure monitoring (ICP) Monitor and an Occlusion Solution Mechanism into a single, integrated device. The primary market for IRRAflow is the United States. The Company\u2019s shareholders comprise Vandel Medical Equipment (CY) Limited, Serendipity Ixora AB (publ) and F.EX Endotherapy Limited, among others.",
    "employeeTotal": "51.0",
    "exchange": "NASDAQ OMX NORDIC",
    "finnhubIndustry": "Health Care",
    "ggroup": "Health Care Equipment & Services",
    "gind": "Health Care Equipment & Supplies",
    "gsector": "Health Care",
    "gsubind": "Health Care Equipment",
    "ipo": "2017-11-22",
    "isin": "SE0008321202",
    "logo": "https://finnhub.io/api/logo?symbol=IRRAS.ST",
    "marketCapitalization": 406.1497,
    "naics": "Medical Equipment and Supplies Manufacturing",
    "naicsNationalIndustry": "Surgical and Medical Instrument Manufacturing",
    "naicsSector": "Manufacturing",
    "naicsSubsector": "Miscellaneous Manufacturing",
    "name": "Irras AB",
    "phone": "4614621151746.0",
    "sedol": "BFNL3M7",
    "shareOutstanding": 66.28134,
    "state": "STOCKHOLM",
    "ticker": "IRRAS.ST",
    "weburl": "https://irras.com/"
}